Retatrutide is a peptide-based compound designed to target metabolic pathways, primarily used for research in metabolic disorders like obesity and insulin resistance
Researchers are examining whether GLP-1 therapies can slow declines in estimated glomerular filtration rate (eGFR) or reduce the risk of end-stage kidney disease
doi: 10.1016/j.pharmthera.2022.108277 102 WangLZhaiY-QXuL-LQiaoCSunXLDingJHet al
Although approved only for treating diabetes, the drug can be used off-label meaning it can be used for something that it has not been approved for in many countries, including Singapore
Injection site reactions are the most common skin-related side effects, presenting as localized redness, swelling, bruising, or itching at the injection site
Does semaglutide cause BOTOX or dermal fillers to wear off faster